A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
- DOI
- 10.1007/s10549-016-4000-z
- Published
- 2016-10-05
- Container
- Breast Cancer Research and Treatment
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-016-4000-z,
title = {A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression},
author = {Nathalie Reix and Charlotte Malina and Marie-Pierre Chenard and Jean-Pierre Bellocq and Stéphanie Delpous and Sébastien Molière and Anthony Sevrin and Karl Neuberger and Catherine Tomasetto and Carole Mathelin},
year = {2016},
journal = {Breast Cancer Research and Treatment},
doi = {10.1007/s10549-016-4000-z},
url = {https://doi.org/10.1007/s10549-016-4000-z}
}RIS
TY - JOUR TI - A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression AU - Nathalie Reix AU - Charlotte Malina AU - Marie-Pierre Chenard AU - Jean-Pierre Bellocq AU - Stéphanie Delpous AU - Sébastien Molière AU - Anthony Sevrin AU - Karl Neuberger AU - Catherine Tomasetto AU - Carole Mathelin PY - 2016 JO - Breast Cancer Research and Treatment DO - 10.1007/s10549-016-4000-z UR - https://doi.org/10.1007/s10549-016-4000-z ER -
APA
Reix, N., Malina, C., Chenard, M., Bellocq, J., Delpous, S., Molière, S., Sevrin, A., Neuberger, K., Tomasetto, C., & Mathelin, C. (2016). A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-016-4000-z
Source records
- crossref · retrieved 2026-09-26T17:37:51.699Z